TEST INSTRUCTIONS
* Read the article.
* Take the test, recording your answers in the test answers section (Section B) of the NCPD enrollment form. Each question has only one correct answer.
* Complete registration information (Section A) and course evaluation (Section C).
* Mail completed test with registration fee to: Lippincott Professional Development, CE Group, 74 Brick Blvd., Bldg., 4 Suite 206A, Brick, NJ 08723.
* Within 4-6 weeks after your NCPD enrollment form is received, you will be notified of your test results.
* If you pass, you will receive a certificate of earned contact hours and answer key. If you fail, you have the option of taking the test again at no additional cost.
* Questions? Contact Lippincott Professional Development: 800-787-8985
* There's only one correct answer for each question. A passing score for this test is 7 correct answers.
This article has been approved by the Orthopaedic Nurses Certification Board for Category A credit toward recertification as an ONC.
* For questions, contact Lippincott Professional Development: 1-800-787-8985.
* Registration deadline is December 5, 2025.
PROVIDER ACCREDITATION
Lippincott Professional Development will award 2.0 contact hours for this nursing continuing professional development activity.
Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia, Georgia, West Virginia, New Mexico, South Carolina, and Florida, CE Broker #50-1223. Your certificate is valid in all states.
Disclosure: The author and planners have disclosed that they have no financial relationships related to this article.
Payment and Discounts: The registration fee for this test is $10.00 for NAON members and $20.00 for nonmembers.
NCPD TEST QUESTIONS
LEARNING OUTCOME: Seventy-five percent of participants will demonstrate knowledge of a study evaluating total knee and hip arthroplasty patients' journey through a new destination center of excellence (DCOE) program, reviewing acute perioperative course trajectories, and reporting clinical outcomes by achieving a minimum score of 70% on the outcomes-based posttest.
LEARNING OBJECTIVES: After completing this continuing professional development activity, the participant will apply knowledge gained to:
1. Choose the essential elements of the planning phase of the new DCOE program for total knee and hip arthroplasty patients.
2. Select the results of the evaluation of the efficacy of the new DCOE program.
3. Identify the authors' conclusions after reviewing the data they collected for their evaluation of the program.
1. The developers of the DCOE program decided that, if concerns should arise during a patient's postoperative period after discharge, the primary means of addressing the situation would be by
a. scheduling a telemedicine visit with the surgical team.
b. transporting the patient back to the joint arthroplasty center.
c. arranging an in-person visit with a local home health agency.
2. Patients requiring total knee or hip arthroplasty would be eligible for the DCOE program if they met the other program criteria and had
a. quit smoking at least 2 weeks prior to surgery.
b. a hemoglobin A1c of no higher than 6.5%.
c. chronic joint pain.
3. After surgery, patients would
a. remain in the hospital for 2 nights.
b. stay nearby for outpatient physical therapy for 2 weeks.
c. have an in-person appointment with the surgical team at 1 week.
4. Six weeks of venous thromboembolism prophylaxis would be indicated for
a. all patients in the program.
b. only patients who had specific risk factors for a thromboembolic event.
c. only those patients who had a documented history of a previous thromboembolic event.
5. Results of the evaluation of the DCOE program showed that two participants developed major complications during the acute perioperative period, one with deep vein thrombosis and one with
a. stroke.
b. pulmonary embolism.
c. myocardial infarction.
6. One patient had to undergo reoperation after total knee arthroplasty (TKA) 9 months postoperatively for
a. infection.
b. nerve pain.
c. dislocation.
7. For patients who underwent total joint arthroplasty (TJA), the final mean outcomes scores in all four measures were
a. fair.
b. good.
c. excellent.
8. The authors noted their belief that a primary reason the DCOE program mitigated the possible adverse events as well as it did could be the
a. motivation of the participants.
b. additional staff hired for the program.
c. desirable geographic location for travelers.
9. Compared with the total hip arthroplasty patients, the TKA patients had a rate of reoperation that was
a. lower.
b. higher.
c. about the same.
10. In the entire DCOE cohort of 100 TJA patients, how many required revision arthroplasty after having pain and limited function from failed ingrowth of the acetabular component?
a. one
b. three
c. five